Erişkin Bağışıklamasında Grip Aşısı
Epidemiler sırasında yüksek oranda mortalite ve morbiditeye yol açmasının yanı sıra,olası bir pandemiye neden olabileceği de kabul edilen grip, tüm dünya için önemli bir sağlıksorunudur. Bu enfeksiyondan korunmada en etkili yaklaşım aşıların kullanımıdır. Bu yazıdagribin önemi ve gripden korunmada kullanılan aşıların özelliklerine değinilecektir.
___
- 1. Glaser CA, Gilliam S, Thompson WW et al. Medical care capacity
for influenza outbreaks, Los Angeles. Emerg Infect Dis
2002;8: 569.
2. Simonsen L, Fukuda K, Schonberger LB, Cox NJ. The impact
of influenza epidemics on hospitalizations. J Infect Dis
2000;181: 831.
3. Thompson WW, Shay DK, Weintraub E et al. Mortality associated
with influenza and RSV. JAMA 2003;289: 179.
4. Nicholson KG, Wood JM, Zambon M. Influenza. Lancet
2003;362: 1733.
5. Kilbourne ED. Influenza pandemics of the 20th century. Emerg
Infect Dis 2006;12: 9.
6. Szucs T. The socio-economic burden of influenza. J Antimicrob
Chemother 1999; 44, Topic B:11.
7. Bridges CB, Katz JM, Levandowski RA, Cox NJ. Inactivated influenza
vaccines. “Vaccines, Eds: S Plotkin, W Orenstein, P Offit”
kitabında, s. 259, 5. baskı, Saunders Elsevier, Çin, 2008.
8. Poehling KA, Edwards KM, Weinberg GA et al. The underrecognized
burden of influenza in young children. N Engl J
Med 2006;355: 31.
9. Nguyen-Van-Tam JS. Epidemiology of influenza.”Textbook of
Influenza, Eds. KG Nicholson, RG Webster, AJ Hay” kitabında,
s.181, Blackwell Science, Oxford, 1998.
10. Molinari NAM, Ortega-Sanchez IR, Messonnier ML et al. The
annual impact of seasonal influenza in the US: measuring disease
burden and costs. Vaccine 2007; 25: 5086.
11. Eccles R. Understanding the symptoms of the common cold
and influenza. Lancet Infect Dis 2005; 5: 718.
12. Cashat-Cruz M, Morales-Aguirre JJ, Mendoza-Azpiri M. Respiratory
tract infections in children in developing countries.
Sem Pediatr Infect Dis 2005, 16: 84.
13. Izurieta HS, Thompson WW, Kramarz P et al. Influenza and
the rates of hospitalization for respiratory disease among infants
and young children. N Engl J Med 2000; 342: 232.
14. Neuzil KM, Melen BG, Wright PF, Mitchel EF, Griffin MR. The
effect of influenza on hospitalizations, outpatient visits, and courses
of antibiotics in children. N Engl J Med 2000; 342:225.
15. Poehling KA, Edwards KM, Weinberg GA et al. The underrecognized
burden of influenza in young children. N Engl J
Med 2006; 355: 31.
16. Neuzil KM, Reed GW, Mitchel EF, Griffin MR. Influenza-associated
morbidity and mortality in young and middle-aged
women. JAMA 1999; 281: 901.
17. Kynel J, Prochazka B, Goddard NL et al. A study of excess mortality
during influenza epidemics in the Czech Republic, 1982-
2000. Euro J Epidemiol 2005; 20: 365.
18. Horimoto T, Kawaoka Y. Influenza: lessons from past pandemics,
warnings from current incidents. Nature Rev Microbiol
2005; 3: 591.
19. Nicholson KG. Human influenza. ”Textbook of Influenza, Eds.
KG Nicholson, RG Webster, AJ Hay” kitabında, s.219,
Blackwell Science, Oxford, 1998.
20. Simonsen L, Viboud C, Taylor RJ, Miller MA. The epidemiology
of influenza and its control. “Influenza vaccines for the
future, Eds. R Rappuoli, G Del Giudice” kitabında, s. 65, Birkhauser,
Verlag, Basel, 2008.
21. Smith DJ, Lapedes AS, de Jong JC et al: Mapping the antigenic
and genetic evolution of Influenza virus. Science 2004; 305: 371.
22. Belshe RB, Walker R, Stoddard JJ, Kemble G, Maassab HF,
Mendelman PM. Influenza vaccine-live. “Vaccines, Eds: S Plotkin,
W Orenstein, P Offit” kitabında, s. 291, 5. baskı, Saunders
Elsevier, Çin, 2008.
23. WHO: Influenza vaccines. Wkly Epidemiol Rec 2000;77: 230.
24. Hannoun C, Megas F, Piercy J: Immunogenicity and protective
efficacy of influenza vaccination. Virus Research
2004;103: 133.
25. Govaert TME, Thijs CTMCN, Masurel N, Sprenger MJW, Dinant
GJ, Knottnerus JA: The efficacy of influenza vaccination
in elderly individulas. A randomized double-blind placebo-
controlled trial. JAMA 1994;272: 1661.
26. Beyer WEP: Heterogeneity of case-definitions used in vaccine
effectiveness studies and its impact on meta-analysis. Vaccine
2006;24: 6602.
27. Nichol KL, Nordin J, Mullooly J et al: Influenza vaccination
and reduction in hospitalizations for cardiac disease and stroke
among the elderly. N Engl J Med 2003; 348: 1322.
28. Vu T, Farish S, Jenkins M, Kelly H: A meta-analysis of effectiveness
of influenza vaccine in persons aged 65 years and over
living in the community. Vaccine 2002; 20: 1831.
29. Maciosek MV, Solberg LI, Coffield AB, Edwards NM, Goodman
MJ: Influenza vaccination. Health impact and cost effectiveness
among adults aged 50 to 64 and 65 and older. Am J
Prev Med 2006;31: 72.
30. Hara M, Sakamoto T, Tanaka K: Effectiveness of influenza vaccination
in preventing influenza-like illness among community-
dwelling elderly: population-based cohort study in Japan.
Vaccine 2006;24: 5546.
31. Kramarz P, DeStefano F, Gargiullo PM et al. Does influenza
vaccination prevent asthma exacerbations in children? J
Pediatr 2001;138: 306.
32. Hanania NA, Atmar RL, Castro M: Influenza vaccine in patients
with asthma. Expert Rev Vaccines 2006;5: 111.
33. Yap FH, Ho PL, Lam KF, et al: Excess hospital admissions
for pneumonia, chronic obstructive pulmonary disease, heart
failure during influenza seasons in Hong Kong. J Med Virol
2004;73: 617.
34. Naghavi M, Barlas Z, Siadaty S et al: Association of influenza
vaccination and reduced risk of recurrent myocardial infarction.
Circulation 2000;102: 3039.
35. Jimenez-Garcia R, Hernandez-Barrera V, Garrido PC, del
Pozo SVF, de Miguel AG: Influenza vaccination among cardiovascular
disease sufferers in Spain: related factors and
trend, 1993-2003. Vaccine 2006;24: 5073.
www.kliniktipdergisi.com 63
36. Van den Akker L, Verheij TJM, Buskens E: Clinical effectiveness
of first and repeat influenza vaccination in adults and
elderly diabetic patients. Diabetes Care 2006;29: 1771.
37. Centre for Diseases Control and Prevention: Prevention and
control of influenza. Recommendations of the advisory committee
on immunization practices (ACIP), 2008. MMWR
2008;57: 1.
38. Jordan R, Connock M, Albon E et al. Universal vaccination
of children against influenza: are there indirect benefits to the
community? A systematic review of the evidence. Vaccine
2006;24: 1047.
39. Harper SA, Fukuda K, Uyeki TM et al. Prevention and control
of influenza. Recommendations of the Advisory Committee on
Immunization Practices (ACIP). MMWR 2005;54(RR-8):1.
40. Negri E, Colombo C, Giordano L, Groth N, Apolone G, La
Vecchia C: Influenza vaccine in healthy children: a meta-analysis.
Vaccine 2005;23: 2851.
41. Heikkinen T, Ruuskanen O, Waris M et al. Influenza vaccination
in the prevention of acute otitis media in children. Am J
Dis Child 1991;145: 445.
42. Esposito S, Marchisio P, Cavagna R et al. Effectiveness of influenza
vaccination of children with recurrent respiratory tract
infections in reducing respiratory-related morbidity within the
households. Vaccine 2003;21: 3162.
43. Principi N, Esposito s, Gasparini R et al. Burden of influenza
in healthy children and their households. Arch Dis Child
2004;89: 1002.
44. Reichert TA, Sugaya N, Fedson DS, Glezen WP, Simonsen L,
Tashiro M: The Japanese experience with vaccinating schoolchildren
against influenza. N Engl J Med 2001;344: 889.
45. Pearson ML, Bridges CB, Harper SA: Influenza vaccination
of health-care personel. Recommendations of the Healthcare
Infection Control Practices Advisory Committee (HICPAC)
and the Advisory Committee on Immunization Practices
(ACIP). MMWR 2006;55: 1.
46. Thomas RE, Jefferson TO, Demicheli V, Rivetti D: Influenza
vaccination for health-care workers who work with elderly people
in institutions: a systematic review. Lancet Infect Dis
2006;6: 273.
47. Nichol KL, Lind A, Margolis KL, et al: The effectiveness of
vaccination against influenza in healthy, working adults. N Engl
J Med 1995;333: 889.
48. Aballea S, Martin M, Chancellor J, Carrat F, Weinstein M:
Cost-effectiveness analysis of influenza vaccination among people
aged 50 to 64 in France. J Econ Med 2006;24: 267.
49. Keech M, scott AJ, Ryan PJJ: The impact of influenza and influenza-
like illness on productivity and healthcare resource
utilization in a working population. Occup Med 1998;48: 85.
50. O’Reilly FW, Stevens AB: Sickness absence due to influenza.
Occup Med 2002;52: 265.
51. Nichol KL: Cost-benefit analysis of a strategy to vaccinate healthy
working adults against influenza. Arch Inter Med
2001;161: 749.
52. Campbell DS, Rumley MH: Cost-effectiveness of the influenza
vaccine in a healthy, working-age population. J Occup Environ
Med 1997;39: 408.
53. Postma MJ, Jansema P, van Genugten ML et al: Pharmacoeconomics
of vaccinating healthy working adults against influenza:
reviewing the available evidence. Drugs 2002;62: 1013.
54. Mustafa AN, Gessner BD, Ismail R et al: A case-control study
of influenza vaccine effectiveness among Malaysian pilgrims
attending the Haj in Saudi Arabia. Int J Infect Dis 2003;7: 210.
55. Gatrad AR, Shafi S, Memish ZA, Sheikh A: Hajj and the risk
of influenza. Brit Med J 2006;333: 1182.
56. The macroepidemiology of influenza vaccination in 56 countries,
1997-2003. Vaccine 2005;23: 5133.
57. Szucs T, Auzanneau N, Lamerain E et al: Influenza vaccination
coverage rate in Europe during the winter of 2005-2006.
2nd International conference on Influenza Vaccines for the
world, 18-20 Ekim 2006, Viyana.
58. Walker FJ, singleton JA, Lu P et al. Influenza vaccination of
healthcare workers in the United States, 1989-2002. Infect Control
Hosp Epidemiol 2006;27: 257.
59. Norton SP, Scheifele DW, Bettinger JA, West RM: Influenza vaccination
in paediatric nurses: cross-sectional study of coverage,
refusal, and factors in acceptance. Vaccine 2008;26: 2942.
60. Szucs T, Müler D: Influenza vaccination coverage rates in five
European countries-a population based cross-sectional
analysis of two consecutive influenza seasons. Vaccine
2005;23: 5055.
61. Centers for Disease Control and Prevention. Influenza vaccination
coverage among persons with asthma-United States,
2005-06 influenza season. MMWR 2008;57: 653.
62. Centers for Disease Control and Prevention. Influenza vaccination
levels among person aged > 65 years and among persons
aged 18-64 years with high-risk conditions-United States,
2003. MMWR 2005;54: 1045.
63. Taşbakan MS, Pullukçu H, Sipahi H, Taşbakan MI: Kronik
obstruktif akciğer hastalığı olgularında influenza aşılanma
oranları ve bilgi düzeylerinin değerlendirilmesi. İnfek Derg
2007;21. 89.
64. Naz H, Aykın N, Çevik FÇ, Uğur M, Yaşer Z: Hastane personelinde
influenza aşılaması: yan etkiler ve aşılamaya yaklaşım.
ANKEM Derg 2007;21 (Ek 1): 8.
65. Kemble G, Greenberg H: Novel generations of influenza vaccines.
Vaccine 2003;21: 1789.
66. Piedra PA, Gaglani MJ, KOzinetz CA et al: Herd immunity
in adults against influenza-related illnesses with use of the trivalent-
live attenuated influenza vaccine (CAIV-T) in children.
Vaccine 2005;23: 1540.
67. Belshe RB: Current status of live attenuated influenza virus
vaccine in the US. Virus Research 2004;103: 177.
68. Romanova J, Katinger D, Ferko B et al: Live cold-adapted influenza
A vaccine produced in Vero cell lien. Virus Research
2004;103: 187.
69. La Montagne JR, Fauci AS. Intradermal influenza vaccination-
Can less be more? N Engl J Med 2004;351: 2330.
70. Holland D, Booy R, De Looze F et al. Intradermal Influenza
vaccine administrered using a new microinjection system produces
superior immunogenicity in elderly adults: a randomized
controlled trial. J Infect Dis 2008;198. 650.
71. Ambrose CS, Levin MJ. The rationale for quadrivalent influenza
vaccines. Hum Vaccin Immunother 2012; 8:81.